Introduce Leronlimab in Subcu, Perc, New Tech 6

This code signifies the administration of Leronlimab, a monoclonal antibody, directly into the subcutaneous tissue. This is a percutaneous (through the skin) delivery method for a novel therapeutic agent.

This code is used when Leronlimab is injected subcutaneously for conditions such as HIV infection, where it acts as a CCR5 antagonist, or in oncology settings for its potential immunomodulatory effects. It applies to inpatient encounters where this specific drug is administered via this route.

• Verify that Leronlimab (PRO 140) is the specific monoclonal antibody administered.
• Confirm the administration route was subcutaneous and not intravenous or intramuscular.
• Ensure the procedure occurred during an inpatient stay to use an ICD-10-PCS code.